Dexcom Inc
Change company Symbol lookup
Select an option...
DXCM Dexcom Inc
ACMR ACM Research Inc
SDY SPDR® S&P Dividend ETF
DIS Walt Disney Co
AAPL Apple Inc
MLM Martin Marietta Materials Inc
GOOG Alphabet Inc
FCNTX Fidelity® Contrafund® Fund
MSFT Microsoft Corp
GLPG Galapagos NV
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.

Price
Delayed
$361.14
Day's Change
3.80 (1.06%)
Bid
--
Ask
--
B/A Size
--
Day's High
370.38
Day's Low
361.14
Volume
(Below Average)

Today's volume of 361,534 shares is on pace to be lower than DXCM's 10-day average volume of 925,310 shares.

361,534

Company Profile

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.

Valuation Ratios

Price/Earnings (TTM)
70.57x
Price/Sales (TTM)
17.46x
Price/Book (MRQ)
18.59x
Price/Cash Flow (TTM)
60.08x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

April 2021
Current Month
3.6M
Previous Month
3.6M
Percent of Float
3.79%
Days to Cover
7.7557 Days

Share Information

DXCM is in a share class of common stock
Float
95.8M
Shares Outstanding
96.7M
Institutions Holding Shares
1,040
92.97%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Kevin R. SayerChmn.
  • Jereme M. SylvainCFO
  • Quentin S. BlackfordCOO
  • Jake Steven LeachExec.VP
  • Donald M. AbbeyExec.VP

Address

Insider Trading

During the most recent quarter, 176K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.